Evidence map›Paper›PMID 27347329›Full record

ArticleAmerican journal of translational research2016

Autologous preconditioned mesenchymal stem cell sheets improve left ventricular function in a rabbit old myocardial infarction model.

Yuya Tanaka, Bungo Shirasawa, Yuriko Takeuchi, Daichi Kawamura, Tamami Nakamura, Makoto Samura, Arata Nishimoto, Koji Ueno, Noriyasu Morikage, Tohru Hosoyama and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Vascular stem/progenitor cells: functions and signaling pathways.Cellular and molecular life sciences : CMLS · 2018
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yuya TanakaDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Bungo ShirasawaDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of MedicineUbe, Japan; Department of Medical Education, Yamaguchi University Graduate School of MedicineUbe, Japan.
Yuriko TakeuchiDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Daichi KawamuraDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Tamami NakamuraDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Makoto SamuraDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Arata NishimotoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Koji UenoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of MedicineUbe, Japan; Center for Regenerative Medicine, Yamaguchi University Graduate School of MedicineUbe, Japan.
Noriyasu MorikageDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Tohru HosoyamaDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of MedicineUbe, Japan; Center for Regenerative Medicine, Yamaguchi University Graduate School of MedicineUbe, Japan.
Kimikazu HamanoDepartment of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine Ube, Japan.
Yamaguchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal stem cells (MSCs) constitute one of the most powerful tools for therapeutic angiogenesis in infarcted hearts. However, conventional MSC transplantation approaches result in insufficient therapeutic effects due to poor retention of graft cells in severe ischemic diseases. Cell sheet technology has been developed as a new method to prolong graft cell retention even in ischemic tissue. Recently, we demonstrated that hypoxic pretreatment enhances the therapeutic efficacy of cell sheet implantation in infarcted mouse hearts. In this study, we investigated whether hypoxic pretreatment activates the therapeutic functions of bone marrow-derived MSC (BM-MSC) sheets and improves cardiac function in rabbit infarcted hearts following autologous transplantation. Production of vascular endothelial growth factor (VEGF) was increased in BM-MSC monolayer sheets and it peaked at 48 h under hypoxic culture conditions (2% O2). To examine in vivo effects, preconditioned autologous BM-MSC sheets were implanted into a rabbit old myocardial infarction model. Implantation of preconditioned BM-MSC sheets accelerated angiogenesis in the peri-infarcted area and decreased the infarcted area, leading to improvement of the left ventricular function of the infarcted heart. Importantly, the therapeutic efficacy of the preconditioned BM-MSC sheets was higher than that of standardly cultured sheets. Thus, implantation of autologous preconditioned BM-MSC sheets is a feasible approach for enhancing therapeutic angiogenesis in chronically infarcted hearts.

Indexed as

cell-based therapycell sheethypoxic preconditioningmesenchymal stem cellsOld myocardial infarction

Identifiers

PMID27347329
PMCPMC4891434
OpenAlexW2463835891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.